MedPath

COVID-19 and the Developement of Phobic Fears of Disease

Recruiting
Conditions
COVID19
Registration Number
NCT04359121
Lead Sponsor
Medical University of Graz
Brief Summary

A lot of people suffer from phobias. Phobias concerning certain diseases are not rare. This study will examine whether the COVID-19 (Coronavirus Disease) crisis was able to rise phobias in people and if those with preexisting phobias or fears were more likely to develop a phobia concerning COVID. It will look at different subtypes - physicians, medical staff, general public (not medically affiliated) and patients with psychiatric disorders.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Person gives written consent
  • Persons between 18-90 years of age (men and women)
  • No positive COVID infection known at time of first examination
Exclusion Criteria
  • Dementia, Delirium (not able to give consent)
  • Not fulfilling the inclusion criteria
  • COVID infection known at first examination point

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Development of phobias2 years

Specific Phobia Questionnaire (SPQ): The SPQ consists of 43 items, each rated using a 5-point Likert scale on two dimensions: (1) level of fear, with scores ranging from 0 (no fear) to 4 (extreme fear) and (2) extent to which the fear interferes with one's daily life, with scores ranging from 0 (no interference) to 4 (extreme interference). The SPQ is scored by combining fear ratings of each Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) specific phobia type.

Severity Measure for Specific Phobia-Adult: The total score can range from 0 to 40 with higher scores indicating greater severity of specific phobia.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University of Graz

🇦🇹

Graz, Styria, Austria

Medical University of Graz
🇦🇹Graz, Styria, Austria
Andreas Baranyi, Prof. MD
Contact
+4331638586241
an.baranyi@medunigraz.at

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.